Abstract
Aims
IA-2 is a transmembrane protein found in the dense-core vesicles (DCV) of neuroendocrine cells and one of the major autoantigens in type 1 diabetes. DCV are involved in the secretion of hormones (e.g., insulin) and neurotransmitters. Stimulation of pancreatic β cells with glucose upregulates the expression of IA-2 and an increase in IA-2 results in an increase in the number of DCV. Little is known, however, about the promoter region of IA-2 or the transcriptional factors that regulate the expression of this gene.
Methods
In the present study, we constructed eight deletion fragments from the upstream region of the IA-2 transcription start site and linked them to a luciferase reporter.
Results
By this approach, we have identified a short bp region (−216 to +115) that has strong promoter activity. We also identified a transcription factor, cAMP responsive element-binding protein (CREB), which binds to two CREB-related binding sites located in this region. The binding of CREB to these sites enhanced IA-2 transcription by more than fivefold. We confirmed these findings by site-directed mutagenesis, chromatin immunoprecipitation assays and RNAi inhibition.
Conclusion
Based on these findings, we conclude that the PKA pathway is a critical, but not the exclusive signaling pathway involved in IA-2 gene expression.
Similar content being viewed by others
References
Lan MS, Wasserfall C, Maclaren NK, Notkins AL (1996) IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 93:6367–6370
Lu J, Li Q, Xie H et al (1996) Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci USA 93:2307–2311
Xie J, Zhang B, Lan MS, Notkins AL (1998) Genomic structure and promoter sequence of the insulin-dependent diabetes mellitus autoantigen, IA-2 (PTPRN). Genomics 54:338–343
Cai T, Hirai H, Zhang G et al (2011) Deletion of Ia-2 and/or Ia-2β in mice decreases insulin secretion by reducing the number of dense core vesicles. Diabetologia 54:2347–2357
Kim SM, Power A, Brown TM et al (2009) Deletion of the secretory vesicle proteins IA-2 and IA-2β disrupts circadian rhythms of cardiovascular and physical activity. FASEB J 23:3226–3232
Harashima S, Clark A, Christie MR, Notkins AL (2005) The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretion. Proc Natl Acad Sci USA 102:8704–8709
Cai T, Chen X, Wang R et al (2011) Expression of insulinoma-associated 2 (INSM2) in pancreatic islet cells is regulated by the transcription factors Ngn3 and NeuroD1. Endocrinology 152:1961–1969
Miyazaki J, Araki K, Yamato E et al (1990) Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126–132
Luther MJ, Hauge-Evans A, Souza KL et al (2006) MIN6 β-cell-β-cell interactions influence insulin secretory responses to nutrients and non-nutrients. Biochem Biophys Res Commun 343:99–104
Seissler J, Nguyen TB, Aust G, Steinbrenner H, Scherbaum WA (2000) Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic β-cells. Diabetes 49:1137–1141
Lobner K, Steinbrenner H, Roberts GA et al (2002) Different regulated expression of the tyrosine phosphatase-like proteins IA-2 and phogrin by glucose and insulin in pancreatic islets: relationship to development of insulin secretory responses in early life. Diabetes 51:2982–2988
Henquin JC, Nenquin M, Szollosi A, Kubosaki A, Notkins AL (2008) Insulin secretion in islets from mice with a double knockout for the dense core vesicle proteins islet antigen-2 (IA-2) and IA-2β. J Endocrinol 196:573–581
Katti MV, Sakharkar MK, Ranjekar PK, Gupta VS (2000) TRES: comparative promoter sequence analysis. Bioinformatics 16:739–740
Misra UK, Pizzo SV (2005) Coordinate regulation of forskolin-induced cellular proliferation in macrophages by protein kinase A/cAMP-response element-binding protein (CREB) and Epac1-Rap1 signaling: effects of silencing CREB gene expression on Akt activation. J Biol Chem 280:38276–38289
Hay CW, Ferguson LA, Docherty K (2007) ATF-2 stimulates the human insulin promoter through the conserved CRE2 sequence. Biochim Biophys Acta 1769:79–91
Ban N, Yamada Y, Someya Y et al (2000) Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes 49:1142–1148
Chuang TD, Guh JY, Chiou SJ, Chen HC, Hung WC, Chuang LY (2007) Sp1 and Smad3 are required for high glucose-induced p21(WAF1) gene transcription in LLC-PK1 cells. J Cell Biochem 102:1190–1201
Wutthisathapornchai A, Vongpipatana T, Muangsawat S, Boonsaen T, MacDonald MJ, Jitrapakdee S (2014) Multiple e-boxes in the distal promoter of the rat pyruvate carboxylase gene function as a glucose-responsive element. PLoS One 9:e102730
Jansson D, Ng AC, Fu A, Depatie C, Al Azzabi M, Screaton RA (2008) Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc Natl Acad Sci USA 105:10161–10166
Chepurny OG, Kelley GG, Dzhura I et al (2010) PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2′-O-Me-cAMP-AM in human islets of Langerhans. Am J Physiol Endocrinol Metab 298:E622–E633
Euskirchen G, Snyder M (2004) A plethora of sites. Nat Genet 36:325–326
Fernando R, Vonberg A, Atkins SJ, Pietropaolo S, Pietropaolo M, Smith TJ (2014) Human fibrocytes express multiple antigens associated with autoimmune endocrine diseases. J Clin Endocrinol Metab 99:E796–E803
Klein DC, Bailey MJ, Carter DA et al (2010) Pineal function: impact of microarray analysis. Mol Cell Endocrinol 314:170–183
Chen CL, Mahalingam D, Osmulski P et al (2013) Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate 73:813–826
Xie H, Notkins AL, Lan MS (1996) IA-2, a transmembrane protein tyrosine phosphatase, is expressed in human lung cancer cell lines with neuroendocrine phenotype. Cancer Res 56:2742–2744
Altarejos JY, Montminy M (2011) CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 12:141–151
Delghandi MP, Johannessen M, Moens U (2005) The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell Signal 17:1343–1351
Dalle S, Quoyer J, Varin E, Costes S (2011) Roles and regulation of the transcription factor CREB in pancreatic β-cells. Curr Mol Pharmacol 4:187–195
Van de Velde S, Hogan MF, Montminy M (2011) mTOR links incretin signaling to HIF induction in pancreatic β cells. Proc Natl Acad Sci USA 108:16876–16882
Eberhard CE, Fu A, Reeks C, Screaton RA (2013) CRTC2 is required for β-cell function and proliferation. Endocrinology 154:2308–2317
Acknowledgments
We thank Dr. Raju Gottumukkala for his comments and Charles Wohlenberg for technical help. This research was supported by the Intramural Research Program of the NIH.
Conflict of interest
The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.
Ethical standard
All studies were performed according to NIH guidelines.
Human and animal rights disclosure
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Informed consent disclosure
Informed consent was obtained from all participants prior to inclusion in the study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Managed by Massimo Porta.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Cai, T., Hirai, H., Xu, H. et al. The minimal promoter region of the dense-core vesicle protein IA-2: transcriptional regulation by CREB. Acta Diabetol 52, 573–580 (2015). https://doi.org/10.1007/s00592-014-0689-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-014-0689-5